<scp>CAPN1</scp> promotes malignant behavior and erlotinib resistance mediated by phosphorylation of <scp>c‐Met</scp> and <scp>PIK3R2</scp><i>via</i> degrading <scp>PTPN1</scp> in lung adenocarcinoma

Yi-Chuan Chen(Wuhan Polytechnic University), Fang Liu(Central South University), Jingqun Tang(Central South University), Ting Lu(Nanjing University of Chinese Medicine)
Thoracic Cancer
May 12, 2020
Cited by 24


Related Papers